Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer

Abstract

Programmed death ligand-1 (PD-L1), which is highly expressed in gastric cancers, interacts with programmed death-1 (PD-1) on T cells and is involved in T-cell immune resistance. To increase the therapeutic safety and accuracy of PD-1/PD-L1 blockade, RNA interference through targeted gene delivery was performed in our study. We developed folic acid (FA)- and disulfide (SS)–polyethylene glycol (PEG)-conjugated polyethylenimine (PEI) complexed with superparamagnetic iron oxide Fe 3 O 4 nanoparticles (SPIONs) as a siRNA-delivery system for PD-L1 knockdown. The characterization, binding ability, cytotoxicity, transfection efficiency, and cellular internalization of the polyplex were determined. At nitrogen:phosphate (N:P) ratios of 10 or above, the FA-PEG-SS-PEI-SPIONs bound to PD-L1 siRNA to form a polyplex with a diameter of approximately 120 nm. Cell-viability assays showed that the polyplex had minimal cytotoxicity at low N:P ratios. The FA-conjugated polyplex showed higher transfection efficiency and cellular internalization in the folate receptor-overexpressing gastric cancer cell line SGC-7901 than a non-FA-conjugated polyplex. Subsequently, we adopted the targeted FA-PEG-SS-PEI-SPION/siRNA polyplexes at an N:P ratio of 10 for function studies. Cellular magnetic resonance imaging (MRI) showed that the polyplex could also act as a T 2 -weighted contrast agent for cancer MRI. Furthermore, one of four PD-L1 siRNAs exhibited effective PD-L1 knockdown in PD-L1-overexpressing SGC-7901. To determine the effects of the functionalized polyplex on T-cell function, we established a coculture model of activated T cells and SGC-7901 cells and demonstrated changes in secreted cytokines. Our findings highlight the potential of this class of multifunctional theranostic nanoparticles for effective targeted PD-L1-knockdown therapy and MRI diagnosis in gastric cancers.

Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers

“…Two other types of inorganic delivery vehicles, namely, silica-based ( Niut et al, 2012 ) and superparamagnetic iron oxide ( Taratula et al, 2011 ; Luo et al, 2017 ) nanoparticles have been proposed as nucleic acid carriers due to their enhanced loading capacity and the possibility to monitor biodistribution, respectively. These materials cannot innately promote endosomal disruption and need additional chemical modifications to tune their endosomal escape capabilities.…”

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy

“…13,14 Previous studies showed that simultaneously delivering chemotherapeutic drugs and siRNA via a single targeted vector was more effective in treating some cancers than sequential administration of two separate vectors with one drug in each. 15 This finding indicates that simultaneous delivery of chemotherapeutic drugs and suitable amount of siRNA into the same tumor plays an important role in the cancer treatments. 16 Emerging evidence has proposed that human homeobox protein (Nanog) is a excellent target in cancer therapy owing to its regulation of cancer cell proliferation, metastasis and apoptosis.…”

Radiation Enhancement with Polyethyleneimine-Coated Gold Nanoparticles Under MV Photons

“…PEI, which is used as a coating in this study, is a cationic polymer that binds to the anionic cell membrane phospholipids and enables uptake. [36] It can be used as a gene delivery vehicle [37], a contrast agent for imaging [38,39], and a biosensor for glutamate detection. [40] Chithrani et al evaluated the size and shape dependence of AuNPs' uptake into mammalian cells, and observed the highest uptake and radiosensitization with approximately 50 nm compared to the 14 nm and 70 nm.…”